ATRX and neoplasm: Furthermore, we investigated the distribution of co-occurrence and mutually exclusive mutations in groups, and found that a unique ATRX-IDH1 co-occurrence and the majority of exclusive mutations had been discovered in high-risk group (Figure 7C) with significantly elevated tumor mutational burden (TMB) (Figure 7D).